Serotonin-releasing effects of substituted piperazines in vitro - PubMed (original) (raw)
Serotonin-releasing effects of substituted piperazines in vitro
D J Pettibone et al. Biochem Pharmacol. 1984.
Abstract
The effects of various piperazine-containing compounds on the release of endogenous serotonin (5-HT) from rat hypothalamic slices were evaluated. Incubation of hypothalamic slices with m-chlorophenylpiperazine ( mCPP ) or m- trifluoromethylphenylpiperazine ( mTFMPP ) evoked a potent, dose-dependent release of endogenous 5-HT that was similar in magnitude to that seen with tryptamine, p-chloroamphetamine, or fenfluramine. In the presence of the 5-HT uptake blockers fluoxetine or chlorimipramine, this release was reduced dramatically. Furthermore, removal of calcium from the incubation medium had little effect on the drug-induced release, suggesting that the release mechanism involved displacement of 5-HT stores and not depolarization-induced exocytosis. Trazodone, MK-212, and quipazine had only small effects on release. These studies show that several piperazine-containing compounds can evoke a potent release of endogenous stores of hypothalamic 5-HT in vitro, actions which should be considered together with their direct agonist activity when interpreting the CNS effects in vivo.
Similar articles
- A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
White FJ, Appel JB. White FJ, et al. Psychopharmacology (Berl). 1981;73(2):110-5. doi: 10.1007/BF00429199. Psychopharmacology (Berl). 1981. PMID: 6785800 - Interactions of trazodone with serotonin neurons and receptors.
Fuller RW, Snoddy HD, Cohen ML. Fuller RW, et al. Neuropharmacology. 1984 May;23(5):539-44. doi: 10.1016/0028-3908(84)90027-3. Neuropharmacology. 1984. PMID: 6429562 - Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
Baumann MH, Rutter JJ, Auerbach SB. Baumann MH, et al. Neuropharmacology. 1993 Dec;32(12):1381-6. doi: 10.1016/0028-3908(93)90034-z. Neuropharmacology. 1993. PMID: 8152528 - Serotonergic stimulation of pituitary-adrenocortical function in rats.
Fuller RW. Fuller RW. Neuroendocrinology. 1981 Feb;32(2):118-27. doi: 10.1159/000123142. Neuroendocrinology. 1981. PMID: 7010191 Review. No abstract available.
Cited by
- The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo.
Nissbrandt H, Waters N, Hjorth S. Nissbrandt H, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):12-9. doi: 10.1007/BF00167564. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1328893 - Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
Babich JW, Graham WA, Fischman AJ. Babich JW, et al. Br J Cancer. 1996 Sep;74(6):917-24. doi: 10.1038/bjc.1996.457. Br J Cancer. 1996. PMID: 8826858 Free PMC article. - Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study.
Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Kahn RS, et al. Psychopharmacology (Berl). 1990;100(3):339-44. doi: 10.1007/BF02244603. Psychopharmacology (Berl). 1990. PMID: 2156278 - Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments.
Wozniak KM, Aulakh CS, Hill JL, Murphy DL. Wozniak KM, et al. Psychopharmacology (Berl). 1989;97(2):269-74. doi: 10.1007/BF00442262. Psychopharmacology (Berl). 1989. PMID: 2498937 - Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers.
Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM. Murphy DL, et al. Psychopharmacology (Berl). 1989;98(2):275-82. doi: 10.1007/BF00444705. Psychopharmacology (Berl). 1989. PMID: 2502799 Clinical Trial.